SCHEMBL5439697

SCHEMBL5439697

CC[C@H]1C(=O)NN=C(c2ccccc2OC)c2cc(OC)c(OC)cc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 2/20 0.44
PDE4D Q08499 2/20 0.44
PDE3A Q14432 2/20 0.44
MEN1 O00255 1/20 0.44
CHRM1 P11229 1/20 0.44
KMT2A Q03164 1/20 0.44
KDM4E B2RXH2 3/20 0.38
MPO P05164 1/20 0.38
PTPRC P08575 1/20 0.37
PTPN1 P18031 1/20 0.37
HSD17B10 Q99714 2/20 0.37
TSHR P16473 1/20 0.37
HTT P42858 1/20 0.37
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE3B Q13370 1/20 0.36
CHEK1 O14757 1/20 0.36
ALDH1A1 P00352 1/20 0.36
MAPT P10636 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5424906 1.00 PDE4A (0.44) PDE4APDE4DPDE3AMEN1CHRM1
SCHEMBL5426505 0.90 MEN1 (0.41) PDE4APDE4DPDE3AMEN1CHRM1
SCHEMBL5428018 0.90 MEN1 (0.41) PDE4APDE4DPDE3AMEN1CHRM1
SCHEMBL5430941 0.83 PDE4A (0.61) PDE4APDE4DPDE3AMEN1CHRM1
SCHEMBL5428060 0.83 PDE4A (0.61) PDE4APDE4DPDE3AMEN1CHRM1
SCHEMBL7408243 0.81 KDM4E (0.37) MEN1KMT2AKDM4EPTPRCHSD17B10
SCHEMBL5436368 0.78 PDE4A (0.56) PDE4APDE4DPDE3AMEN1CHRM1
SCHEMBL5431284 0.78 PDE4A (0.56) PDE4APDE4DPDE3AMEN1CHRM1
SCHEMBL5424934 0.76 MEN1 (0.69) PDE4APDE4DPDE3AMEN1CHRM1
SCHEMBL5198155 0.76 MEN1 (0.69) PDE4APDE4DPDE3AMEN1CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070161628-A1 Phosphodiesterase inhibitors GREENPHARMA (FR) 2007-07-12 US claimed
US-20070161628-A1 Phosphodiesterase inhibitors GREENPHARMA (FR) 2007-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070161628-A1 Phosphodiesterase inhibitors PDE5A, PDE3A, PDE3B PDE4A 6/4885PDE4D 12/4885PDE3A 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.